Milagen
San Francisco, United States· Est. 2015
Milagen spent over 25 years in research and development to find the best screening diagnostic option for the earlier detection of cancer and especially its recurrence.
Private Company
Total funding raised: $4.2M
About
Milagen spent over 25 years in research and development to find the best screening diagnostic option for the earlier detection of cancer and especially its recurrence.
Diagnostics
Funding History
1Total raised:$4.2M
Seed$4.2MNov 15, 2020